Skip to content

A study to see the result of planned cancer surgery in COVID-19 survivors

Outcomes of elective cancer surgery in COVID-19 survivors: An observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029847
Enrollment
600
Registered
2020-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. patients with a confirmed diagnosis of cancer 2. and a confirmed COVID diagnosis (by RT PCR) 3. who were planned to undergo surgery as part of their cancer treatment plan

Exclusion criteria

Exclusion criteria: Patients with clinical or radiological suspicion of COVID without a positive RT PCR test will be excluded

Design outcomes

Primary

MeasureTime frame
In COVID-recovered cancer patients who underwent surgery 1. 30 day all-cause mortality 2. 30-day morbidity (as per Clavien Dindo classification) 3. Correlation of mortality and morbidity with severity of COVIDTimepoint: 30 days post surgery

Secondary

MeasureTime frame
Among all patients planned for surgery, who developed COVID, the proportion who had: 1. Any changes in cardiopulmonary status post-COVID (for example, repeat ECHO, repeat six minute walk test) 2. cancellation or postponement of surgery (with cause) 3. additional evaluation/ testing / specialist referralTimepoint: Pre surgery

Countries

India

Contacts

Public ContactDr Priya Ranganathan

Tata Memorial Centre

jdivatia@yahoo.com9869077435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026